Rushang D. Patel, MD, discusses the background to the single center experience with ruxolitinib as treatment of patients with chronic graft-versus-host disease.
Rushang D. Patel, MD
Articles by Rushang D. Patel, MD
Latest Updated Articles
Ruxolitinib Appears Promising as Treatment of Chronic Graft-Versus-Host DiseasePublished: February 23rd 2020 | Updated: